Trending...
- Are Productions Missing the Full Opportunities of Social Media Marketing?
- Legacy Gospel Series Project - New Previously Unreleased Recordings
- Prospect Home Finance becomes the official sponsor of the San Diego Gulls!
LOS ANGELES - Californer -- One key understanding pharma, biotech and medical device companies learn – usually the hard way – is that when you combine a drug or biologic with a delivery device or software as a medical device (SaMD), the sum is a unique entity to itself. This is especially true in the eyes of regulatory bodies. FDA/MDR rulings on combination products require quality systems to be integrated for both drug and device. The amalgamated system is not simply made up of both quality systems together but is a newly created system to assess how the products work together, not as individuals. As more and more companies build their combination product portfolios, they often require expert guidance to develop this specific genre for successful regulatory approval and consumer benefit.
During 2020, a year of many pivots, new priorities and business assessments in the pharmaceutical industry particularly, Suttons Creek, a combination product device consultancy based on the Los Angeles area, spent its time building up its executive team and consultant roster to ensure its clients' needs would be covered from initial strategic planning, through all elements of device development and regulatory approval, all the way to commercialization and post-launch activities. Four of the biggest areas of growth were in Commercial, Human Factors, EU MDR Preparedness and In Vitro Diagnostic / Companion Diagnostic specialties.
More on The Californer
Seeing that many industry players, big and small, had a knowledge disconnect between device developers and the commercial teams that would take the combination products to market, Suttons Creek brought on a new Director of Sales & Marketing, Stephanie Sobel (previously from the Commercial Organization of AstraZeneca). Stephanie uses her pharmaceutical industry experience to bridge the gap with client commercial teams through specialized trainings and strategic guidance for all aspects of commercialization of combination products.
Suttons Creek recently found that combination product developers tend to be unfamiliar, and often undervalue or even ignore the benefits of performing Human Factors as part of their device development. It is a critical element in the validation, regulatory approval and user experience of a combination product, but also an element that can be new to pharma and biotech companies taking their first few steps into the combination product arena. To help increase awareness about, and support for, this critical aspect of device development, Suttons Creek hired Matthew Nare, a Human Factors and clinical observations research specialist, and brought three Human Factors consultants onto his team. Another new specialty now strongly represented in the Suttons Creek consultant pool is In Vitro Diagnostic and Companion Diagnostic, thanks to Suttons Creek's new Director of Regulatory, Rob Schulz. Diagnostic filings are a unique "animal" all to themselves and require specialized knowledge of rules, regulations, core technology and best practices.
More on The Californer
Visit us at https://www.suttonscreek.com.
During 2020, a year of many pivots, new priorities and business assessments in the pharmaceutical industry particularly, Suttons Creek, a combination product device consultancy based on the Los Angeles area, spent its time building up its executive team and consultant roster to ensure its clients' needs would be covered from initial strategic planning, through all elements of device development and regulatory approval, all the way to commercialization and post-launch activities. Four of the biggest areas of growth were in Commercial, Human Factors, EU MDR Preparedness and In Vitro Diagnostic / Companion Diagnostic specialties.
More on The Californer
- San Jose Community Leaders Advocate for Return to In-Person Learning
- Ventura County Workforce Development Board Seeks Public Comments On 4-Year Workforce Plan
- Majid Al Futtaim Retail Expands Tally Robot Deployment to a Dozen Carrefour Stores in the UAE
- Southern California Black Chamber of Commerce - Long Beach Area Names Sharifah Hardie President
- San Jose: Free Legal Services Available for Low-Income Tenants and Landlords in San José
Seeing that many industry players, big and small, had a knowledge disconnect between device developers and the commercial teams that would take the combination products to market, Suttons Creek brought on a new Director of Sales & Marketing, Stephanie Sobel (previously from the Commercial Organization of AstraZeneca). Stephanie uses her pharmaceutical industry experience to bridge the gap with client commercial teams through specialized trainings and strategic guidance for all aspects of commercialization of combination products.
Suttons Creek recently found that combination product developers tend to be unfamiliar, and often undervalue or even ignore the benefits of performing Human Factors as part of their device development. It is a critical element in the validation, regulatory approval and user experience of a combination product, but also an element that can be new to pharma and biotech companies taking their first few steps into the combination product arena. To help increase awareness about, and support for, this critical aspect of device development, Suttons Creek hired Matthew Nare, a Human Factors and clinical observations research specialist, and brought three Human Factors consultants onto his team. Another new specialty now strongly represented in the Suttons Creek consultant pool is In Vitro Diagnostic and Companion Diagnostic, thanks to Suttons Creek's new Director of Regulatory, Rob Schulz. Diagnostic filings are a unique "animal" all to themselves and require specialized knowledge of rules, regulations, core technology and best practices.
More on The Californer
- Mayor London Breed Announces Spending Plan for Historic Reinvestment in San Francisco's African-American Community
- Triller Fight Club Secures Teófimo López Against George Kambosos Jr. Bout
- Sandline Global Fortifies World-Class Executive Team: Glenn Hopper Joins as Chief Financial Officer
- RSTOR Enhances Software Defined Cloud Platform to Support Hybrid, Multi-Cloud Enterprise Infrastructures
- Private Placement Markets adds Credit Life & Disability Insurance to its Mortgage Loan Programs
Visit us at https://www.suttonscreek.com.
Source: Suttons Creek, Inc.
Filed Under: Biotech
0 Comments
Latest on The Californer
- Get ready for Spring Break with a poem/potential song lyrics called "The New Coronavirus Blues"
- Dermatologist Fabio Gontijo wins the attention of celebrities with infallible procedures for women's beauty
- Local Barbers Refuse To Stop Taking Walk Ins In 2021. What They Did Was Inevitable
- Bronx DWI Lawyer Announces New Website
- Recording Artist "Cherne" Crystal Brown auditions for Sony Music, Atlantic Records and Capitol Records and it doesn't stop there
- San Francisco: City Leaders Join Together to Announce Two New Initiatives to Prevent Recidivism and Gun Violence
- San Jose: Draft IS/Addendum: Our Lady of La Vang Church (SP19-028)
- San Jose: Draft IS/Addendum: 645 Horning Street Gas Station, Food, and Storage Project (PDA16-027-02)
- San Francisco Moves to Phase 1B of COVID-19 Vaccinations, Expands Eligibility to Educators, Child Care, Emergency Services, Food and Agriculture Workers
- All-new Virtual Music Lounge Turntable Adds Amanda Levensohn as Creative Director
- Honorary Oscar-Winner Charles Burnett brings his award winning film on COVID-19 / Black Hollywood to the Prestigious Pan African 2021 Film Festival
- In a year of recession, Lantek closes 2020 with record sales figures and customer numbers
- SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Ebix, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- Emmy Nominated Television Producer, Erika Bryant To Release New Book Titled Doing It Scared
- The 2021 Encore Gospel Celebration of Unity Virtual Concert a must see star-studded event
- New Phase 3 Clinical Study Finds Nutritional Protocol Including Nicotinamide Riboside Accelerates Recovery in Mild-to-Moderate COVID-19 Patients
- The Koedo Kawagoe Spring Festival Celebrates the Arrival of Springtime in Kawagoe, Japan
- Dropbox, Inc. Announces Upsize and Pricing of $1.306 Billion Convertible Senior Notes Offering
- Santa Monica Democratic Club Votes Unanimously to Approve Resolution for Columbia Sussex to Cease Future Operations in City, as Labor Dispute with UNITE HERE Local 11 Enters Fifth Year
- Long Beach: 58% of Seniors Vaccinated